Associated Papers
Familial Renal Glucosuria and Potential Pharmacogenetic Impact on Sodium-Glucose Cotransporter-2 Inhibitors.
Allaire P et al.
Kidney360, 2025
39412882 (PubMed )
Supplement: kidney360-6-521-s005.xlsx › Table_S2._SLC5A2_Variants
Genetic and clinical characterization of familial renal glucosuria.
Xu L et al.
Clinical Kidney Journal, 2024
Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor.
Ren Q et al.
Journal of Diabetes, 2022
35229480 (PubMed )
Supplement: JDB-14-216-s001.xlsx › Sheet1
Solute carrier SLC16A12 is critical for creatine and guanidinoacetate handling in the kidney.
Verouti SN et al.
American Journal of Physiology. Renal Physiology, 2021
Inherited Renal Tubulopathies-Challenges and Controversies.
Iancu D et al.
Genes, 2020
A novel compound heterozygous mutation in SLC5A2 contributes to familial renal glucosuria in a Chinese family, and a review of the relevant literature.
Li S et al.
Molecular Medicine Reports, 2019
Sequence variants associating with urinary biomarkers.
Benonisdottir S et al.
Human Molecular Genetics, 2019
Mutation in the Monocarboxylate Transporter 12 Gene Affects Guanidinoacetate Excretion but Does Not Cause Glucosuria.
Dhayat N et al.
Journal of the American Society of Nephrology : Jasn, 2016
Select a paper to view details